UPS (NYSE: UPS) today announced it will purchase Hungary-based pharmaceutical logistics company, CEMELOG Zrt, as part of its ongoing global growth and investment strategy. The acquisition further strengthens UPS's healthcare reach and expertise in Europe, enabling comprehensive, compliant services to customers in the pharmaceutical, biotech and medical device industries across the increasingly important markets of Central and Eastern Europe.
UPS expects to complete the transaction in the second quarter of 2013, subject to customary closing conditions. Per company policy, terms of the deal are not disclosed.
Based outside of Budapest, CEMELOG has offered customers across Central and Eastern Europe tailor-made healthcare logistics solutions for the last fourteen years. Backed by a strong regional network, advanced warehousing management systems, full quality assurance services and an experienced workforce, the company helps healthcare clients maximize supply chain efficiencies, meet regulatory requirements and deliver products reliably and securely. CEMELOG's customers include some of the most recognized healthcare brands in the world.